Berenberg Bank downgraded shares of Smith & Nephew plc (LON:SN) to a hold rating in a research report released on Thursday morning. They currently have GBX 1,340 ($16.58) price target on the stock, down from their previous price target of GBX 1,485 ($18.38).
SN has been the subject of several other research reports. JPMorgan Chase & Co. restated a neutral rating and set a GBX 1,199 ($14.84) price target on shares of Smith & Nephew plc in a research note on Wednesday, September 14th. Jefferies Group raised their price objective on shares of Smith & Nephew plc from GBX 1,375 ($17.02) to GBX 1,420 ($17.57) and gave the stock a buy rating in a report on Thursday, June 30th. Goldman Sachs Group Inc. reaffirmed a buy rating on shares of Smith & Nephew plc in a report on Tuesday, September 13th. BNP Paribas reaffirmed an outperform rating and issued a GBX 1,335 ($16.52) price objective on shares of Smith & Nephew plc in a report on Monday, June 27th. Finally, Numis Securities Ltd reaffirmed an add rating and issued a GBX 1,242 ($15.37) price objective on shares of Smith & Nephew plc in a report on Friday, June 24th. Ten investment analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. Smith & Nephew plc presently has a consensus rating of Hold and an average target price of GBX 1,283.77 ($15.89).
Shares of Smith & Nephew plc (LON:SN) opened at 1244.00 on Thursday. The company’s market cap is GBX 11.12 billion. Smith & Nephew plc has a one year low of GBX 1,040.36 and a one year high of GBX 1,324.00. The stock’s 50 day moving average price is GBX 1,238.89 and its 200-day moving average price is GBX 1,211.77.
In other Smith & Nephew plc news, insider Bottomley ,Virginia bought 238 shares of the firm’s stock in a transaction that occurred on Monday, August 15th. The shares were bought at an average price of GBX 1,290 ($15.97) per share, for a total transaction of £3,070.20 ($3,799.75).
About Smith & Nephew plc
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. The Company offers various product franchises, which include Knee implants, Hip implants, Sports Medicine Joint Repair, Arthroscopy Enabling Technologies, Trauma and Extremities, Other Surgical Businesses, Advanced Wound Care, Advanced Wound Devices and Advanced Wound Bioactives.
Receive News & Ratings for Smith & Nephew plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew plc and related companies with MarketBeat.com's FREE daily email newsletter.